Bulletin
Investor Alert

New York Markets Close in:

Illumina Inc.

NAS: ILMN

GO
/marketstate/country/us

Countdown to close

 --Real time quotes

Jan 25, 2022, 3:56 p.m.

/zigman2/quotes/203509482/composite

$

344.79

Change

-20.17 -5.53%

Volume

Volume 877,907

Real time quotes

/zigman2/quotes/203509482/composite

Previous close

$ 364.96

$ 344.79

Change

-20.17 -5.53%

Day low

Day high

$344.03

$358.80

Open

52 week low

52 week high

$341.03

$555.77

Open

Insider Actions for Illumina Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
01/12/2022 Susan H. Tousi
SVP, Chief Commercial Officer
800   Disposition at $425 per share. 340,000
01/08/2022 Aimee Hoyt
SVP, Chief People Officer
115   Derivative/Non-derivative trans. at $362.28 per share. 41,662
12/28/2021 Susan H. Tousi
SVP, Chief Commercial Officer
100   Disposition at $387.06 per share. 38,706
12/22/2021 Charles E. Dadswell
SVP & General Counsel
322   Disposition at $380.29 per share. 122,453
12/08/2021 Susan H. Tousi
SVP, Chief Commercial Officer
100   Disposition at $375 per share. 37,500
11/22/2021 Charles E. Dadswell
SVP & General Counsel
314   Disposition at $377.86 per share. 118,648
11/12/2021 Alex Aravanis
SVP, Chief Technology Officer
361   Disposition at $386.35 per share. 139,472
11/08/2021 Phillip G. Febbo
SVP Chief Medical Officer
1,000   Disposition at $406.83 per share. 406,830
11/05/2021 Francis A. deSouza
President and CEO; Director
3,604   Derivative/Non-derivative trans. at $408.14 per share. 1,470,936
11/05/2021 Susan H. Tousi
SVP, Chief Commercial Officer
982   Derivative/Non-derivative trans. at $408.14 per share. 400,793
11/05/2021 Sam A. Samad
SVP and CFO
723   Derivative/Non-derivative trans. at $408.14 per share. 295,085
11/05/2021 Kevin Carl Pegels
Chief of Global Operations
574   Derivative/Non-derivative trans. at $408.14 per share. 234,272
11/05/2021 Alex Aravanis
SVP, Chief Technology Officer
191   Derivative/Non-derivative trans. at $408.14 per share. 77,954
11/05/2021 Joydeep Goswami
SVP Corp Business Development
264   Derivative/Non-derivative trans. at $408.14 per share. 107,748
11/05/2021 Charles E. Dadswell
SVP & General Counsel
739   Derivative/Non-derivative trans. at $408.14 per share. 301,615
11/05/2021 Aimee Hoyt
SVP, Chief People Officer
434   Derivative/Non-derivative trans. at $408.14 per share. 177,132
11/05/2021 Phillip G. Febbo
SVP Chief Medical Officer
446   Derivative/Non-derivative trans. at $408.14 per share. 182,030
11/05/2021 Kathy Reeves
SVP, Chief Marketing Officer
97   Derivative/Non-derivative trans. at $408.14 per share. 39,589
11/02/2021 Alex Aravanis
SVP, Chief Technology Officer
483   Disposition at $417.62 per share. 201,710
11/02/2021 Alex Aravanis
SVP, Chief Technology Officer
200   Disposition at $416.48 per share. 83,296
11/02/2021 Alex Aravanis
SVP, Chief Technology Officer
393   Disposition at $413.24 per share. 162,403
11/02/2021 Alex Aravanis
SVP, Chief Technology Officer
366   Disposition at $412.15 per share. 150,846
11/02/2021 Alex Aravanis
SVP, Chief Technology Officer
645   Disposition at $411.47 per share. 265,398
11/02/2021 Alex Aravanis
SVP, Chief Technology Officer
639   Disposition at $410.47 per share. 262,290
11/02/2021 Alex Aravanis
SVP, Chief Technology Officer
200   Disposition at $409.28 per share. 81,856

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
27 Sales
0
17,118
Last 6 months
1 Purchases
47 Sales
21,653
35,759
Last 12 months
36 Purchases
101 Sales
109,622
107,738

Officers and Executives

Mr. Francis A. deSouza
President, Chief Executive Officer & Director
Mr. Robert P. Ragusa
Chief Operations Officer
Mr. Sam A. Samad
Chief Financial Officer & Senior Vice President
Dr. Alex Aravanis
CTO, Head-Research & Product Development
Mr. Steve Phillpott
Chief Information Officer & Senior Vice President
Dr. Phillip G. Febbo
Chief Medical Officer
Dr. Joydeep Goswami
Chief Strategy & Corporate Development Officer
Mr. Min-Jui Shen
Director-Scientific Operations & Research
Ms. Susan H. Tousi
Chief Commercial Officer
Dr. Craig Michael Ciesla
Vice President
Mr. Charles E. Dadswell
Secretary, Senior VP & Compliance Officer
Ms. Paula Lynn Dowdy
SVP & GM-Commercial Operations, Europe
Ms. Kathy Reeves
Chief Marketing Officer
Mr. Jose A. Torres
Chief Accounting Officer & Vice President
Ms. Juliet C. Cunningham
Vice President-Investor Relations
Ms. Aimee Hoyt
Chief People Officer & Senior Vice President
Dr. John Wendell Thompson
Chairman
Dr. Scott Gottlieb
Independent Director
Dr. Robert S. Epstein
Independent Director
Dr. Frances Hamilton Arnold
Independent Director
Mr. Philip W. Schiller
Independent Director
Ms. Caroline D. Dorsa
Independent Director
Dr. Gary S. Guthart
Independent Director
Ms. Susan E. Siegel
Independent Director
Link to MarketWatch's Slice.